Leah's visionary approach to addressing medical challenges will be showcased at the NAI conference, disrupting traditional adhesion methods and unlocking possibilities across various industries. With a track record of groundbreaking discoveries, awards, and cross-disciplinary collaborations, Leah has established herself as a respected figure in the field of scientific innovation.

The NAI conference provides an esteemed platform for inventors like Leah to unveil game-changing innovations, fostering collaboration and propelling the world forward. Attendees will witness the unveiling of the AnastoTape electroadhesion gel, gaining valuable insights that will inspire future advancements and ignite new possibilities in the field of adhesion technology.

AnastoTape addresses a critical need in the medical field. With over 1 million intestinal anastomosis surgeries performed annually in the US and a failure rate of over 10%, there is a pressing demand for safer and more effective methods of tissue repair. Traditional sutures, while effective, come with significant drawbacks, especially in vulnerable populations.

Gelectric Medical's innovative solution eliminates the need for sutures altogether. AnastoTape utilizes an electrical stimulus to develop strong adhesion, offering a superior alternative to current surgical adhesives and sealants. Importantly, its reversible nature allows for easy correction in case of placement errors.

"We are honored to receive this grant from the Maryland Innovation Initiative," said Leah Klein Borden, CEO at Gelectric Medical Inc. "This support will propel our mission to revolutionize surgical procedures and improve patient outcomes. We are immensely grateful for this opportunity."

Gelectric Medical Inc. extends its gratitude to the MII program and looks forward to advancing AnastoTape towards commercialization, thereby contributing to the advancement of medical technology and patient care.